Back

Adjunctive Role of SGLT2 Inhibitors in Transthyretin Cardiac Amyloidosis: A Systematic Review and Meta-Analysis

2026-01-19 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

Structured abstractO_ST_ABSBackgroundC_ST_ABSTransthyretin amyloid cardiomyopathy (ATTR-CM) has historically been underdiagnosed but has recently become increasingly recognized due to advances in diagnostic techniques and heightened clinical awareness. Despite this progress, treatment options remain limited, as current approved therapies are costly and not widely accessible. Given the benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in broader heart failure (HF) populations, we aime...

Predicted journal destinations